Literature DB >> 33223290

Monodisperse microsphere-based immobilized metal affinity chromatography approach for preparing Antarctic krill phospholipids followed by HILIC-MS analysis.

Qing Shen1, Huanming Wu2, Honghai Wang3, Qiaoling Zhao4, Jing Xue5, Jianfeng Ma6, Haixing Wang7.   

Abstract

Phospholipids enriched krill is a functional food beneficial in cardiovascular diseases. Herein, monodisperse microsphere-based immobilized metal affinity chromatographic material (MM-IMAC) was synthesized with Ti4+ incorporated to enrich phospholipids from krill by coordination with phosphate group. The extract was profiled by hydrophilic interaction chromatography-mass spectrometry (HILIC-MS) with 154 phospholipid molecular species detected. The parameters were loading solvent n-hexane/isopropanol (2:8, v/v), flow rate 0.8 mL·min-1, and eluting volume 1 mL. Besides, eicosapentaenoic and docosahexaenoic acids structured phospholipids were located, such as phosphatidylcholine (PC) 20:5/22:6, phosphatidylinositol (PI) 18:0/20:5, etc. Finally, this method was validated in linearity (R2 ≥ 0.9953), sensitivity (LOD ≤ 0.53 μg·mL-1 and LOQ ≤ 1.66 μg·mL-1), precision (RSDintraday ≤ 4.86% and RSDinterday ≤ 6.25%), and recovery (58-83%). It indicated that the MM-Ti4+-IMAC-HILIC-MS was reliable and efficient in specific study of phospholipids in food matrix.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immobilized metal affinity chromatography; Krill; Lipidomics; Mass spectrometry; Monodisperse microsphere

Year:  2020        PMID: 33223290     DOI: 10.1016/j.foodchem.2020.128585

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  1 in total

1.  Screening of Phospholipids in Plasma of Large-Artery Atherosclerotic and Cardioembolic Stroke Patients With Hydrophilic Interaction Chromatography-Mass Spectrometry.

Authors:  Haixing Wang; Siyan Chen; Zhao Han; Ting Li; Jianfeng Ma; Xi Chen; Jie Pang; Qingcheng Wang; Qing Shen; Manman Zhang
Journal:  Front Mol Biosci       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.